Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2018 Q2- Text added to 2018 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Good
|
New words:
addressing, aforementioned, ankylosing, ASC, Asegua, Asia, baseline, biologic, biosimilar, blueprint, Chicago, CMS, curb, developmental, disposal, DRG, editing, FINCH, focused, genome, HHS, HiFiBiO, Hong, hospital, inpatient, intolerance, JAK, Kong, Lancet, Lastly, lived, notable, NTAP, outlier, physician, poster, Precision, published, registry, role, Tango, TORTUGA, transgenic, Trianni, upfront, Utrecht
Removed:
Amneal, Biotech, carboxylase, centered, dismissal, follicular, irrespective, revised, scheduled, shifted, transformed, voucher
Valuein 2018 Q2 filing- Value in 2018 Q3 filing
Original filings
Filing view